RxDoctor Payments Data

Bahareh Fazilat, MD

Obstetrics & Gynecology · Sherman Oaks, CANPI 1770598534

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,185 of the $5,985 with a category attached, or 86.6%. It is spread thinly across 18 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Among obstetrics & gynecology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,985in general payments, 2019–2025

Across 270 payments — averaging $22.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$818
  • Mimedx Group, Inc.$800
  • Pfizer$737
  • Sumitomo Pharma America, Inc.$723
  • Merz North America, Inc.$628
  • AbbVie$613
  • plus $2K from 12 others

What the payments were for

  • Consulting fees$80013%
  • Food & beverage$5,18587%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,985 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.

See all obstetrics & gynecology providers in California →

Medicare billing

Part B allowed, 2024
$22,831
Medicare patients
43
Services billed
219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol28$1,704

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Sherman Oaks

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →